Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes

European Journal of Preventive Cardiology

Volumn 13, Issue 3, 2006, Pages 388-397

  Scharhag, Jürgen ^a   Urhausen, Axel ^b   Schneider, Günther ^c   Herrmann, Markus ^a,d   Schumacher, Katrin ^a   Haschke, Michaela ^a   Krieg, Anne ^a   Meyer, Tim ^a   Herrmann, Wolfgang ^d   Kindermann, Wilfried ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Hospital Center of Luxembourg   (Luxembourg)

^c Clinic of Radiology   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

B type natriuretic peptide; BNP; echocardiography; exercise; infarction; magnetic resonance imaging; myocardium; NT proBNP sports cardiology; troponin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T;

ADULT; AMINO TERMINAL SEQUENCE; ANAEROBIC CAPACITY; ARTICLE; ATHLETE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ENDURANCE SPORT; EXERCISE; HEART MUSCLE NECROSIS; HUMAN; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZATION; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE;

ADULT; CREATINE KINASE; CREATINE KINASE, MB FORM; ECHOCARDIOGRAPHY; EXERCISE; HEART RATE; HEMATOCRIT; HEMOGLOBINS; HUMANS; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; TROPONIN I; TROPONIN T;

EID: 33748281968     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000219117.33038.90     Document Type: Article

References (37)

1. Maisel A. B-type natriuretic peptide levels: a potential novel “white count” for congestive heart failure. J Card Fail 2001; 7: 183–193.
2. Apple F, Murakami M, Pearce L, Herzog C. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004; 50: 2279–2285.
3. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no st-segment elevation. J Am Coll Cardiol 2002; 40: 437–445.
4. Koller A. Exercise-induced increases in cardiac troponins and prothrombotic markers. Med Sci Sports Exerc 2003; 35: 444–448.
5. Chen Y, Serfass R, Mackey-Bojack S, Kelly K, Titus J, Apple F. Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged exercise. J Appl Physiol 2000; 88: 1749–1755.
6. Koller A, Summer P, Moser H. Regular exercise and subclinical myocardial injury during prolonged aerobic exercise. JAMA 1999; 282: 1816.
7. Ohba H, Takada H, Musha H, Nagashima J, Mori N, Awaya T, et al. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men. Am Heart J 2001; 141: 751–758.
8. Rifai N, Douglas P, O'Toole M, Rimm E, Ginsburg G. Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol 1999; 83: 1085–1089.
9. Shave R, Dawson E, Whyte G, George K, Gaze D, Collinson P. Altered cardiac function and minimal cardiac damage during prolonged exercise. Med Sci Sports Exerc 2004; 36: 1098–1103.
10. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002; 48: 1097–1100.
11. Siegel AJ, Holman BL, Silverman LM, Evans WJ. Normal post-race thallium 201 myocardial perfusion imaging in marathon runners with elevated cardiac enzymes excludes silent myocardial ischemia [abstract]. Med Sci Sports Exerc 1984; 16: 115–116.
12. Siegel AJ, Lewandrowski EL, Chun KY, Sholar MB, Fischman AJ, Lewandrowski KB. Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon. Am J Cardiol 2001; 88: 920–923.
13. Urhausen A, Scharhag J, Herrmann M, Kindermann W. Clinical significance of increased cardiac troponin T and I in participants of ultra-endurance events. Am J Cardiol 2004; 94: 696–698.
14. Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 2005; 150: 1128–1134.
15. Stegmann H, Kindermann W, Schnabel A. Lactate kinetics and individual anaerobic threshold. Int J Sports Med 1981; 2: 160–165.
16. Swain D, Wright R. Prediction of VO2max peak from submaximal cycle ergometry using 50 versus 80 rpm. Med Sci Sports Exerc 1997; 29: 268–272.
17. Dickhuth H, Roecker K, Niess A, Hipp A, Heitkamp H. The echocardiographic determination of volume and muscle mass of the heart. Int J Sports Med 1996; 17: 132–139.
18. Scharhag J, Schneider G, Urhausen A, Rochette V, Kramann B, Kindermann W. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained control subjects determined by magnetic resonance imaging. J Am Coll Cardiol 2002; 40: 1856–1863.
19. Apple F, Quist H, Doyle P, Otto A, Murakami M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49: 1331–1336.
20. Hess G, Runkel S, Zdunek D, Hitzler WE. Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): A study in blood donors. Clin Chim Acta 2005; 360: 187–193.
21. Neumayr G, Pfister R, Mitterbauer G, Eibl G, Hoertnagl H. Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am J Cardiol 2005; 96: 732–735.
22. Shave RE, Whyte GP, George K, Gaze DC, Collinson PO. Prolonged exercise should be considered alongside typical symptoms of acute myocardial infarction when evaluating increases in cardiac troponin T. Heart 2005; 91: 1219–1220.
23. Neumayr G, Pfister R, Mitterbauer G, Maurer A, Gaenzer H, Sturm W, Hoertnagl H, et al. Effect of the “Race across the Alps” in elite cyclists on plasma cardiac troponins I and T. Am J Cardiol 2002; 89: 484–486.
24. Ricciardi M, Wu E, Davidson C, Choi KM, Klocke FJ, Bonow RO, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001; 103: 2780–2783.
25. Wu A, Feng Y. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J 1998; 19 (Suppl N):N25–N29.
26. Chen Y, Zang D, Guo Q, Wei J, Serfass C. Effects of prolonged high intensity running on myocardium in untrained rats [abstract]. Med Sci Sports Exerc 1997; 29: 246.
27. McNeil P, Terasaki M. Coping with the inevitable: how cells repair a torn surface membrane. Nat Cell Biol 2001; 3: E124–E129.
28. Venditti P, Di Meo S. Antioxidants, tissue damage, and endurance in trained and untrained young male rats. Arch Biochem Biophys 1996; 331: 63–68.
29. Burnett JJ. Vasopeptidase inhibition: a new concept in blood pressure management. J Hypertens 1999; 17 (Suppl):S37–S43.
30. Brunner-La Rocca H, Kaye D, Woods R, Hastings J, Esler M. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 2001; 37: 1221–1227.
31. Scharhag J, Urhausen A, Herrmann W, Schneider G, Kramann B, Herrmann W, Kindermann W. No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete's heart and healthy untrained controls. Heart 2004; 90: 1055–1056.
32. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 2000; 97: 4239–4244.
33. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004; 6: 257–260.
34. Konig D, Schumacher Y, Heinrich L, Schmid A, Berg A, Dickhuth H. Myocardial stress after competitive exercise in professional road cyclists. Med Sci Sports Exerc 2003; 35: 1679–1683.
35. Luchner A, Hengstenberg C, Lowel H, Trawinski J, Baumann M, Riegger GA, et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 2002; 39: 99–104.
36. Foote R, Pearlman J, Siegel A, Yeo K. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2005; 16: 1980–1987.
37. Whyte G, George K, Sharma S, Lumley S, Gates P, Prasad K, McKenna WJ. Cardiac fatigue following prolonged endurance exercise of differing distances. Med Sci Sports Exerc 2000; 32: 1067–1072.